Semaglutide is a modified molecule our bodies make, called a GLP-1 analog. It works by increasing insulin production and lowering glucagon secretion as well as targeting areas in the brain that regulate appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts minutes.

Semaglutide acts in the following ways:

• Delays how quickly our stomachs digest food. Leading to a feeling of fullness and satisfaction with smaller meal sizes.
• Slows intestinal motility so you will feel fuller longer after meals.
• Lowers blood sugars, in part by reducing the production of sugar in the liver.
• Stimulates insulin secretion by the pancreas

Tirzepatide acts in the following ways:

• Delays how quickly our stomachs digest food. Leading to a feeling of fullness and satisfaction with smaller meal sizes.
• Slows intestinal motility so you will feel fuller longer after meals.
• Dual action receptors allow for lower blood sugars, in part by reducing the production of sugar in the liver.
• Stimulates insulin secretion by the pancreas.
• GIP increases energy expenditure, resulting in weight loss reductions

• The most common side effects include nausea and constipation.* 
• Patients also report acid reflux, stomach pain, vomiting, and Diarrhea. 
• The risk of serious side effects increases in patients with hypoglycemia, kidney problems, and the risk of allergic reactions.
• Risk of thyroid c-cell Tumor. If you or any family members have been diagnosed with Multiple Endocrine Neoplasia Syndrome Type 2 or Medullary thyroid cancer you should not take Semaglutide and Tirzepatide.
• If you have ever had pancreatitis consult with your medical provider as using Semaglutide or Tirzepatide can increase the risk of developing pancreatitis.

*1 mg/mL of Cyanocobalamin added to reduce nausea side effects in the case of Semaglutide.

*500 mcg/mL of Cyanocobalamin added to reduce nausea side effects in case of Tirzepatide

These medications (Semaglutide and Tirzepatide) are not insulin and should not be used if you have type 1 diabetes or if you develop diabetic ketoacidosis. Semaglutide and Tirzepatide should not be used with any other GLP-1 medications.